| 2711 |
FLUCONA-DENK 100 |
FLUCONAZOLE 100 MG |
CAPSULE |
PVC/PVDC-ALU BLISTER |
CRYPTOCOCCAL MENINGITIS, COCCIDIOIDOMYCOSIS, INVASIVE CANDIDIASIS, MUCOSAL CANDIDIASIS, CHRONIC ORAL ATROPIC CANDIDIASIS, VAGINAL CANDIDIASIS, CANDIDAL BALANITIS, DERMATOMYCOSIS. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
DENK PHARMA GMBH & CO., LTD |
GERMANY |
CERTIFICATE RELEASED |
04 I 4406/18 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 2712 |
FLUIFORT |
CARBOCYSTEINE LYSINE SALT MONOHYDRATE EQUIVALENT TO CARBOCYSTEINE LYSINE SALT 450 MG /5 ML |
SYRUP |
BOTTLE |
IN CONDITIONS WITH EITHER HYPERVISCOUS OR HYPOVISCOUS MUCUS, ACUTE DISORDERS OF THE UPPER AND LOWER RESPIRATORY TRACT. TREATMENT OF EAR, NOSE AND THROAT (ENT) DISORDERS, SUCH AS PHARYNGITIS, TONSILLITIS, LARYNGITIS, RHINITIS, RHINOPHARYNGITIS, OTITIS, SINUSITIS |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
M & H MANUFACTURING CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
03 I 4220/17 |
08-APR-2024 |
07-APR-2027 |
View |
| 2713 |
FLUIFORT |
CARBOCYSTEINE LYSINE SALT MONOHYDRATE 2.86 G EQ. TO CARBOCYSTEINE LYSINE SALT 2.70 G |
POWDER FOR ORAL SOLUTION |
Sachet |
* FLUIFORT IS INDICATED FOR THE TREATMENT OF ACUTE DISORDERS OF THE UPPER AND LOWER RESPIRATORY TRACT.
* FLUIFORT IS ALSO INDICATED FOR THE TREATMENT OF EAR, NOSE AND THROAT (ENT) DISORDERS, SUCH AS PHARYNGITIS, TONSILLITIS, LARYNGITIS, RHINITIS, RHINOPH |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
POLIPHARM CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
03 I 4219/17 |
08-APR-2024 |
07-APR-2027 |
View |
| 2714 |
FLUOPH EYE DROPS |
FLUOROMETHOLONE 100 MG/100 ML |
SUSPENSION |
BOTTLE |
NON-INFECTIOUS ALLERGIC INFLAMMATION OF THE CONJUNCTIVA, CORNEA, ANTERIOR SEGMENT OF THE EYE BALL. POST-OP STATE FOR SQUINT, CATARACT, GLAUCOMA. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
SENG THAI COMPANY CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 5615/23 |
09-Oct-2023 |
08-Oct-2026 |
View |
| 2715 |
FOBAN CREAM |
FUSIDIC ACID 2.0% W/W |
CREAM |
TUBE |
SKIN LESIONS PRIMARILY OR SECONDARILY INFECTED WITH STAPHYLOCOCCUS OR STREPTOCOCCUS |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
HOE PHARMACEUTICALS SDN. BHD |
MALAYSIA |
CERTIFICATE RELEASED |
11 I 1994/00 |
03-Oct-2023 |
02-Oct-2026 |
View |
| 2716 |
FOBAN OINTMENT |
SODIUM FUSIDATE 2 %W/W |
OINTMENT |
Tube |
SKIN LESIONS PRIMARILY OR SECONDARILY INFECTED WITH STAPHYLOCOCCUS OR STREPTOCOCCUS. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
HOE PHARMACEUTICALS SDN. BHD |
MALAYSIA |
CERTIFICATE RELEASED |
11 I 1993/00 |
08-SEP-2022 |
07-SEP-2025 |
View |
| 2717 |
FOBANCORT CREAM |
FUSIDIC ACID 2 % W/W, BETAMETHASONE DIPROPIONATE 0.064% W/W |
CREAM |
Tube |
FOR THE TOPICAL TREATMENT OF INFLAMMATORY DERMATOSES, PSORIASIS, WHERE BACTERIAL INFECTION CAUSED STAPPHYLOCOCCUS AND STREPTOCOCCUS |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
HOE PHARMACEUTICALS SDN. BHD |
MALAYSIA |
CERTIFICATE RELEASED |
11 I 1992/00 |
03-Oct-2023 |
02-Oct-2026 |
View |
| 2718 |
FOBANCORT OINTMENT |
SODIUM FUSIDATE 2.0% W/W , BETAMETHASONE DIPROPIONATE 0.064% W/W EQ.TO BETAMETHASONE 0.05 % |
OINTMENT |
Tube |
INFLAMMATORY DERMATOSES, PSORIASIS WHERE BACTERIAL INFECTION CAUSED BY STAPHYLOCOCCUS OR STREPTOCOCCUS ARE PRESENT OR LIKELY TO OCCUR. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
HOE PHARMACEUTICALS SDN. BHD |
MALAYSIA |
CERTIFICATE RELEASED |
11 I 1995/00 |
08-SEP-2022 |
07-SEP-2025 |
View |
| 2719 |
FOSMICIN FOR IV USE |
STERILE FOSFOMYCIN SODIUM 4G |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
TREATMENT OF THE INFECTIONSDUE TO FOSFOMYCIN-SUSCEPTIBLE STRAINS OF PSEUDOMONAS AERUGINOSA, PROTEUS SP., SERRATIA MARCESCENT, AND MULTIDRUGRESISTANT STRAINS OF STAPHYLOCOCCUS AUREOUS AND ESCHERICHIA COLI IN SEP0TICEMIA, INFECTION OF RESPIRATORY TRACTS, UROGENITAL TRACTDS, ABDOMINAL TRACTS, BONE AND LYMPH NODE |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
MEIJI SEIKA PHARMATECH CO.,LTD., JAPAN |
THAILAND |
CERTIFICATE RELEASED |
04 I 5218/22 |
03-MAR-2025 |
02-MAR-2030 |
View |
| 2720 |
FOSMICIN FOR IV USE |
STERILE FOSFOMYCIN SODIUM 2G |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
TREATMENT OF THE INFECTIONS DUE TO FOSFOMYCIN-SUSCEPTIBLE STRAINS OF PSEUDOMONAS AERUGINOSA, PROTEUS SP., SERRATIA MARCESCENT, AND MULTIDRUG RESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS AND ESCHERICHIA COLI IN SEPTICEMIA, INFECTION OF RESPIRATORY TRACTS, UROGENITAL TRACTS, ABDOMINAL TRACTS, BONE AND LYMPH NODE, HEAD INJURIES AND MENINGITIS. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
MEIJI SEIKA PHARMATECH CO.,LTD., JAPAN |
THAILAND |
CERTIFICATE RELEASED |
04 I 5217/22 |
03-MAR-2025 |
02-MAR-2030 |
View |
